n/a
Abstract Title:

The effects of astaxanthin and docosahexaenoic acid-acylated astaxanthin on Alzheimer's disease in APP/PS1 double transgenic mice.

Abstract Source:

J Agric Food Chem. 2018 Apr 25. Epub 2018 Apr 25. PMID: 29695154

Abstract Author(s):

Hongxia Che, Qian Li, Tiantian Zhang, Dandan Wang, Lu Yang, Jie Xu, Teruyoshi Yanagita, Changhu Xue, Yaoguang Chang, YuMing Wang

Article Affiliation:

Hongxia Che

Abstract:

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with the characteristics of senile plaques, neuro-inflammation, neurofibrillary tangles and destruction of synapse structure stability. Previous studies have verified the protective effects of astaxanthin (AST). However, whether synthesized docosahexaenoic acid-acylated AST diesters (AST-DHA) could delay AD pathogenesis remains unclear. In the present study, APP/PSEN1 (APP/PS1) double transgenic mice were administrated with AST and AST-DHA for 2 months. The results of radial 8-arm maze and Morris water maze tests showed that AST-DHA exerted more significant effects than AST in enhancing learning and memory levels of APP/PS1 mice. Further mechanical studies suggested that AST-DHA was superior to AST in regulating the parameters of oxidative stress, reducing Tau hyper-phosphorylation, suppressing neuro-inflammation and regulating inflammasome expression and activation in APP/PS1 mice. The findings suggested AST-DHA attenuated cognitive disorders by reducing pathological features in APP/PS1 mice, suggesting AST-DHA might be a potential therapeutic agent for Alzheimer's disease.

Study Type : Transgenic Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.